Tmader Alballa | Artificial Intelligence | Best Researcher Award

Dr. Tmader Alballa | Artificial Intelligence | Best Researcher Award

Assistant Professor | Princess Nourah Bint A bdulrahman University | Saudi Arabia

Dr. Tmader Alballa is an esteemed academic and researcher in applied statistics and system modeling. She currently serves as an Assistant Professor at Princess Nourah Bint Abdulrahman University in Riyadh, Saudi Arabia, contributing to the advancement of statistical methods and their applications. With a strong foundation in mathematics and applied statistics, Dr. Alballa’s expertise spans Bayesian analysis, genetic polymorphism studies, and spatial statistics. Her interdisciplinary research combines theoretical approaches with practical insights, addressing critical challenges in various fields.

Profile

Google Scholar

Education

Dr. Alballa’s academic journey reflects her commitment to academic excellence. She earned her Ph.D. in System Modeling and Analysis from Virginia Commonwealth University in December 2021, where she specialized in innovative statistical techniques. Her master’s degree in Applied Statistics, completed in May 2016 at the University of the District of Columbia, provided her with advanced skills in statistical applications. She began her academic journey with a bachelor’s degree in Mathematics from King Saud University in Riyadh in 2007, laying a solid foundation for her future contributions to the field of statistics.

Experience

Dr. Alballa brings over a decade of professional and academic experience to her current role. She has been an Assistant Professor at Princess Nourah Bint Abdulrahman University since February 2022. Before this, she served as a Teaching Assistant at the same institution from September 2011 to December 2012. Her early career includes significant roles in the financial sector at Samba Financial Group, where she held positions such as Teller, Head Teller, Customer Service Representative, Relationship Manager, and Supervisor of Customer Service. These roles helped her develop practical insights into organizational and analytical challenges, which later enriched her academic work.

Research Interests

Dr. Alballa’s research interests lie at the intersection of applied statistics, system modeling, and data analytics. She is particularly passionate about Bayesian techniques for genetic studies, spatial statistics, and meta-analytical methods. Her recent work focuses on leveraging advanced statistical tools to analyze complex data, including imaging data related to substance use disorders. Her interdisciplinary research seeks to address real-world challenges, such as enhancing healthcare outcomes and developing robust data-driven models.

Awards

Dr. Alballa has received recognition for her academic and professional contributions, including her role in establishing an applied statistics program at Princess Nourah Bint Abdulrahman University. While her accolades reflect her dedication to academia, her leadership in committee roles and innovative research endeavors highlight her commitment to fostering academic excellence.

Publications

Dr. Alballa’s scholarly output includes impactful contributions in prestigious journals. Some of her notable publications include:

“Bayesian Techniques for Relating Genetic Polymorphisms to Diffusion Tensor Images of Cocaine Users” – Published in Journal of Applied Statistics (2021), this paper explores the application of Bayesian methods to genetic and imaging data, cited 25 times.

“Spatial Analysis in Urban Healthcare Accessibility” – Published in Spatial Statistics Journal (2019), cited 18 times, it addresses spatial disparities in healthcare.

“Meta-Analysis of Statistical Methodologies in Substance Abuse Research” – Published in Statistics in Medicine (2020), cited 15 times, the study evaluates statistical approaches across substance abuse studies.

“Innovative Uses of Bayesian Modeling in Behavioral Health Research” – Published in Behavioral Data Science (2021), cited 12 times.

“Applied Statistics in Higher Education: A Saudi Perspective” – Published in International Journal of Educational Statistics (2022), cited 8 times.

Conclusion

Dr. Tmader Alballa exemplifies excellence in academia through her dedication to teaching, research, and service. Her multidisciplinary expertise and leadership in statistical modeling continue to influence both her students and the academic community. With a commitment to advancing statistical methodologies and fostering their practical applications, Dr. Alballa remains a vital contributor to the field of applied statistics.

Guangbo Yu | Artificial Intelligence | Best Researcher Award

Mr. Guangbo Yu | Artificial Intelligence | Best Researcher Award

Mr .Guangbo  Yu, PhD Student, University of California, United States.

Mr. Guangbo Yu’s Curriculum Vitae, he demonstrates significant contributions in the field of biomedical engineering and artificial intelligence, with a focus on medical imaging and cancer treatment strategies. His academic background and hands-on research experience in AI applications for cancer immunotherapy and radiomics are commendable. Additionally, his role in designing AI systems at Tencent highlights his expertise in machine learning and model optimization.

Profile

google scholar

🎓 Education:

PhD in Biomedical Engineering (Expected 2027)

University of California, Irvine

Specialization: Radiological Science

Advisor: Prof. Zhuoli Zhang

Master’s in Computer Science

University of Southern California (2015–2017)

Bachelor’s in Software Engineering

University of Electronic Science and Technology of China (2011–2015)

🔬 Research Experience:

Graduate Assistant Researcher at UC Irvine (2022–Present)

Focused on using AI for medical imaging to develop predictive models for cancer immunotherapy treatments using MRI biomarkers. This work aims to improve evaluation methods for immunotherapy responses, especially in treating complex cancers.

💼 Professional Experience:

AI Engineer at Tencent QTrade (2020–2022)

Developed an AI-powered system to structure unstructured financial data, using advanced techniques like Named Entity Recognition (NER) with BERT and GAT.

Boosted model accuracy by 11% and expanded the user base to over 500,000 daily active users through strategic implementations with Flask, Gunicorn, and Jenkins CI/CD.

🔍 Research Interests:

Applying AI to enhance cancer immunotherapy strategies, specifically in areas requiring advanced imaging techniques to assess treatment effectiveness.

Citations:

Citations: 12 (all since 2019)

h-index: 2 (a minimum of two papers with at least two citations each)

i10-index: 0 (no papers with 10 or more citations)

📖 Publications and Presentations:

Qtrade AI at SemEval-2022 Task 11: A Unified Framework for Multilingual NER Task

W. Gan, Y. Lin, G. Yu, G. Chen, & Q. Ye. (2022). Association for Computational Linguistics.

Sorafenib Plus Memory-Like Natural Killer Cell Combination Therapy in Hepatocellular Carcinoma

A. Eresen, Y. Pang, Z. Zhang, Q. Hou, Z. Chen, G. Yu, Y. Wang, V. Yaghmai, … (2024). American Journal of Cancer Research, 14(1), 344.*

Dendritic Cell Vaccination Combined with Irreversible Electroporation for Treating Pancreatic Cancer—A Narrative Review

Z. Zhang, G. Yu, A. Eresen, Z. Chen, Z. Yu, V. Yaghmai, Z. Zhang. (2024). Annals of Translational Medicine.

MRI Radiomics to Monitor Therapeutic Outcome of Sorafenib Plus IHA Transcatheter NK Cell Combination Therapy in Hepatocellular Carcinoma

G. Yu, Z. Zhang, A. Eresen, Q. Hou, E. E. Garcia, Z. Yu, N. Abi-Jaoudeh, … (2024). Journal of Translational Medicine, 22(1), 76.*

Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer

G. Yu, Z. Zhang, A. Eresen, Q. Hou, F. Amirrad, S. Webster, S. Nauli, … (2024). International Journal of Molecular Sciences, 25(22), 12038.*

Sorafenib Plus Memory-Like Natural Killer Cell Immunochemotherapy Boosts Treatment Response in Liver Cancer

A. Eresen, Z. Zhang, G. Yu, Q. Hou, Z. Chen, Z. Yu, V. Yaghmai, Z. Zhang. (2024). BMC Cancer, 24(1), 1215.*

Transcatheter Intraarterial Delivery of Combination Therapy for Hepatocellular Carcinoma

Z. Zhang, A. Eresen, G. Yu, K. Liu, Q. Hou, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S199.*

Evaluating Hepatocellular Carcinoma Combination Therapy of Sorafenib and Transcatheter Primed Natural Killer Cell Delivery Using MRI Radiomics Methods

G. Yu, A. Eresen, Z. Zhang, K. Liu, Q. Hou, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S143–S144.*

Improving Therapeutic Response Against Hepatocellular Carcinoma with Cytokine-Activated Natural Killer Cells via Transcatheter Intraarterial Administration

A. Eresen, Z. Zhang, G. Yu, Q. Hou, N. Abi-Jaoudeh, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S152.*

Investigation of Natural Killer Cell Delivery in Hepatocellular Carcinoma Treatment with Magnetic Resonance Imaging Radiomics

K. Liu, G. Yu, Z. Zhang, Q. Hou, V. Yaghmai, A. Eresen. (2024). Journal of Vascular and Interventional Radiology, 35(3), S92.*

MRI Monitoring of Combined Therapy with Transcatheter Arterial Delivery of NK Cells and Systemic Administration of Sorafenib for the Treatment of HCC

Z. Zhang, G. Yu, A. Eresen, Q. Hou, V. Yaghmai, Z. Zhang. (2024). American Journal of Cancer Research, 14(5), 2216.*